VTT Technical Research Centre of Finland Ltd., Espoo, Finland.
Aalto University, Department of Biotechnology and Chemical Technology, Espoo, Finland.
Plant Biotechnol J. 2018 Feb;16(2):404-414. doi: 10.1111/pbi.12780. Epub 2017 Aug 1.
Purification is a bottleneck and a major cost factor in the production of antibodies. We set out to engineer a bifunctional fusion protein from two building blocks, Protein A and a hydrophobin, aiming at low-cost and scalable antibody capturing in solutions. Immunoglobulin-binding Protein A is widely used in affinity-based purification. The hydrophobin fusion tag, on the other hand, has been shown to enable purification by two-phase separation. Protein A was fused to two different hydrophobin tags, HFBI or II, and expressed transiently in Nicotiana benthamiana. The hydrophobins enhanced accumulation up to 35-fold, yielding up to 25% of total soluble protein. Both fused and nonfused Protein A accumulated in protein bodies. Hence, the increased yield could not be attributed to HFB-induced protein body formation. We also demonstrated production of HFBI-Protein A fusion protein in tobacco BY-2 suspension cells in 30 l scale, with a yield of 35 mg/l. Efficient partitioning to the surfactant phase confirmed that the fusion proteins retained the amphipathic properties of the hydrophobin block. The reversible antibody-binding capacity of the Protein A block was similar to the nonfused Protein A. The best-performing fusion protein was tested in capturing antibodies from hybridoma culture supernatant with two-phase separation. The fusion protein was able to carry target antibodies to the surfactant phase and subsequently release them back to the aqueous phase after a change in pH. This report demonstrates the potential of hydrophobin fusion proteins for novel applications, such as harvesting antibodies in solutions.
纯化是抗体生产中的一个瓶颈和主要成本因素。我们着手设计一种由两个构建块(Protein A 和一种疏水蛋白)组成的双功能融合蛋白,旨在低成本和可扩展地在溶液中捕获抗体。免疫球蛋白结合蛋白 A 广泛用于基于亲和性的纯化。另一方面,疏水蛋白融合标签已被证明能够通过两相分离进行纯化。将 Protein A 融合到两种不同的疏水蛋白标签 HFBI 或 II 上,并在 Nicotiana benthamiana 中瞬时表达。疏水蛋白将积累量提高了 35 倍,最高可达总可溶性蛋白的 25%。融合和非融合的 Protein A 都在蛋白体中积累。因此,增加的产量不能归因于 HFB 诱导的蛋白体形成。我们还在 30 升规模的烟草 BY-2 悬浮细胞中展示了 HFBI-Protein A 融合蛋白的生产,产量为 35 毫克/升。高效地分配到表面活性剂相中证实了融合蛋白保留了疏水蛋白块的两亲性特性。Protein A 块的可逆抗体结合能力与非融合的 Protein A 相似。性能最佳的融合蛋白在两相分离中从杂交瘤培养上清液中捕获抗体进行了测试。融合蛋白能够将目标抗体带到表面活性剂相中,并在 pH 变化后将其释放回水相。本报告证明了疏水蛋白融合蛋白在新型应用中的潜力,例如在溶液中收获抗体。